Alzamend Neuro (ALZN) Assets (2020 - 2026)
Alzamend Neuro (ALZN) posted Assets of $8.54 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), up 35.0% from $6.33 million a year earlier and up 310.8% from the prior quarter.
Powered by 
Analysis
Alzamend Neuro (ALZN) Assets (2020 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), Alzamend Neuro's Assets came in at $2.08 million, down 54.8% from FY2025.
- Annual Assets shows a five-year compound annual growth rate of -6.5% (FY2021 to FY2026).
- In prior fiscal years, Alzamend Neuro's Assets was $4.6 million in FY2025 (+628.8%), $631,588 in FY2024 (-89.3%), $5.92 million in FY2023 (-59.2%) and $14.52 million in FY2022 (+398.4%).
- The fiscal Q1 2027 figure stands as the highest quarterly Assets since fiscal Q2 2023.
- On a year-over-year basis, Assets increased in six of the last eight quarters, with growth averaging 216.1%.
- The strongest year-over-year quarter for Assets in the past five years was fiscal Q4 2025, with growth of 628.8%; the weakest was fiscal Q3 2024, with a decline of 90.8%.
- According to Business Quant data, Assets for the three prior fiscal quarters was $2.08 million (Q4 2026), $4.04 million (Q3 2026) and $5.09 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Alzamend Neuro | 5.73 Mn | -9.73 Mn | - | 8.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 8.54 Mn |
| Apr 30, 2026 | 2.08 Mn |
| Jan 31, 2026 | 4.04 Mn |
| Oct 31, 2025 | 5.09 Mn |
| Jul 31, 2025 | 6.33 Mn |
| Apr 30, 2025 | 4.60 Mn |
| Jan 31, 2025 | 4.18 Mn |
| Oct 31, 2024 | 5.01 Mn |
| Jul 31, 2024 | 1.67 Mn |
| Apr 30, 2024 | 631,588.00 |
| Jan 31, 2024 | 782,636.00 |
| Oct 31, 2023 | 983,597.00 |
| Jul 31, 2023 | 2.63 Mn |
| Apr 30, 2023 | 5.92 Mn |
| Jan 31, 2023 | 8.50 Mn |
| Oct 31, 2022 | 10.42 Mn |
| Jul 31, 2022 | 12.21 Mn |
| Apr 30, 2022 | 14.52 Mn |
| Jan 31, 2022 | 12.43 Mn |
| Oct 31, 2021 | 14.50 Mn |
API Access
Alzamend Neuro Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();